Track the latest Xtant Medical Hldgs insider trading activity. Stay informed on recent buys, sells, and market impact for Xtant Medical Hldgs stock.
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
At Xtant Medical Holdings Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 73.11M shares worth $30.71M, meanwhile, insiders have report no purchases in the last 30 days.
Apr 14, 2025 | ORBIMED ADVISORS LLCOrbimed ROF II LLC | 10% OWNER | -73.11M | $0.42 | -$30.71M | SELL | -100.00% | 0.00 | Apr 10 | View |
Nov 17, 2023 | Kevin Brandt | CHIEF COMMERCIAL OFFICER | 41.67K | $1.20 | $49.84K | BUY | 5.38% | 815.86K | Nov 17 | View |
Jan 19, 2023 | Scott Neils | CHIEF FINANCIAL OFFICER | -8.67K | $0.61 | -$5.28K | SELL | -2.10% | 403.96K | Jan 18 | View |
Oct 20, 2022 | Sean Browne | PRESIDENT AND CEO | -131.10K | $0.65 | -$85.83K | SELL | -8.01% | 1.51M | Oct 18 - Oct 19 | View |
Oct 11, 2022 | Stavros Vizirgianakis | DIRECTOR | 2.26M | $0.48 | $1.09M | BUY | 63.16% | 5.85M | Oct 07 | View |
Aug 17, 2022 | Kevin Brandt | CHIEF COMMERCIAL OFFICER | 387.08K | $0.49 | -$11.22K | GRANT | 122.30% | 703.57K | Aug 15 - Aug 17 | View |
Aug 17, 2022 | Scott Neils | CHIEF FINANCIAL OFFICER | 245.53K | $0.48 | -$3.07K | GRANT | 146.93% | 412.63K | Aug 15 - Aug 17 | View |
Browse insider trades on all stocks.